Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Bone Loss and Fracture in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis Publisher Pubmed



Yazdan Panah M1, 2 ; Vaheb S2 ; Moases Ghaffary E2 ; Shaygannejad V2, 3 ; Zabeti A4 ; Mirmosayyeb O2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Student Research Committee, Shahrekord University of Medical Sciences, Shahrekord, Iran
  2. 2. Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Neurology, University of Cincinnati, Cincinnati, OH, United States

Source: Multiple Sclerosis and Related Disorders Published:2024


Abstract

Background: People with multiple sclerosis (PwMS) exhibit reduced bone mineral density (BMD) across several anatomical regions. Studies have indicated that PwMS are at a heightened risk of fractures due to decreased BMD and increased prevalence of osteopenia and osteoporosis. This study aimed to investigate the prevalence and risk of osteopenia, osteoporosis, and fracture among PwMS. Methods: Relevant studies were identified through comprehensive searches of databases (PubMed/MEDLINE, Scopus, Embase, and Web of Science) from January 1, 2000, to January 21, 2024. R software version 4.4.0 and random-effects models were employed to estimate the pooled prevalence, odds ratio (OR), and risk ratio (RR) of osteopenia, osteoporosis, and fracture among PwMS, along with their respective 95 % confidence intervals (CIs). Results: From a total of 2039 articles, 51 studies with 1,503,785 PwMS met our inclusion criteria. The pooled prevalence of osteopenia, osteoporosis, and overall fracture among PwMS was 41.41 % (95 % CI: 36.14% to 46.69 %, I2=97 %), 14.21 % (95 % CI: 10.75 % to 17.68 %, I2=99 %), and 12.84 % (95 % CI: 8.49 % to 17.19 %, I2 = 100 %), respectively. The likelihood of osteopenia (OR=2.02, 95 % CI: 1.46 to 2.8, p-value<0.01, I2=17 %) and osteoporosis (OR=1.71, 95 % CI: 1.27 to 2.31, p-value<0.01, I2=74 %), as well as the probability of overall fracture (RR=1.86, 95 % CI: 1.61 to 2.14, p-value<0.01, I2=74 %) were significantly higher in PwMS than healthy controls (HCs). Conclusion: PwMS were at a substantially increased risk of developing osteopenia (2-fold), osteoporosis (1.7-fold), and overall fractures (1.9-fold). Well-designed studies are needed to explore these associations further. © 2024 Elsevier B.V.
Related Docs
View other Related Docs
1. The Prevalence of Osteoporosis/Osteopenia in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Neurological Sciences (2022)
2. Magnetic Resonance Imaging-Based Biomarkers of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Meta-Analysis, Journal of Neurology (2025)
3. Association Between Diffusion Tensor Imaging Measurements and Cognitive Performances in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2025)
4. The Relationship Between Optical Coherence Tomography and Magnetic Resonance Imaging Measurements in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis, Journal of the Neurological Sciences (2025)
5. Prevalence and Incidence of Multiple Sclerosis in Isfahan, Iran Between 1996 and 2021: A Population-Based Study, Multiple Sclerosis and Related Disorders (2024)
6. Multiple Sclerosis Epidemiology in Asia and Oceania; a Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2021)
7. Clinical Characteristics and Disability Progression of Early-And Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis, Journal of Clinical Medicine (2020)
8. A Study on Bone Mass Density Using Dual Energy X-Ray Absorptiometry: Does High Body Mass Index Have Protective Effect on Bone Density in Obese Patients?, Journal of Research in Medical Sciences (2020)
Experts (# of related papers)
View all Related Experts
Vahid Shaygannejad (36)
Masoud Etemadifar (17)
Other Related Docs
9. T-Score Discordance Between Hip and Spine in Diagnosis of Osteoporosis in Patients From Iranian Population, Acta Medica Iranica (2022)
10. Assessment of Intelligence Quotient in Patients With Neuromyelitis Optica Spectrum Disease and Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2023)
11. Exposure to Heavy Metals and the Risk of Osteopenia or Osteoporosis: A Systematic Review and Meta-Analysis, Osteoporosis International (2020)
12. Assessment of Mental Health, Knowledge, and Attitude of Patients With Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in Response to 2019 Novel Coronavirus, Neurological Sciences (2021)
13. Examining the Environmental Risk Factors of Progressive-Onset and Relapsing-Onset Multiple Sclerosis: Recruitment Challenges, Potential Bias, and Statistical Strategies, Journal of Neurology (2024)
14. Incidence and Prevalence of Multiple Sclerosis in Persian Gulf Area: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2020)
15. The Role of Dietary Inflammation in the Risk of Osteoporosis in Iranian Postmenopausal Women: A Case-Control Study, Scientific Reports (2025)
16. The Association Between Psoriasis and Psoriatic Arthritis With the Risk of Osteoporosis, Osteopenia and Bone Fractures: A Systematic Review and Meta-Analysis, International Journal of Clinical Practice (2021)
17. The Diagnostic Performance of Ai-Based Algorithms to Discriminate Between Nmosd and Ms Using Mri Features: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2024)
18. The Findings of Bone Mineral Densitometry Following Preventive Treatment With Alendronate in Menopausal Women With Osteopenia: What Is the Best Dose?, Journal of Isfahan Medical School (2020)
19. Effect of Stevia on Blood Glucose and Hba1c: A Meta-Analysis, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2024)
20. Definition of a Population-Specific Dual Energy X-Ray Absorptiometry Reference Standard in Isfahani Women, International Journal of Rheumatic Diseases (2008)
21. Impact of the Covid-19 Pandemic on the Psychological Status and Cortisol Level of Multiple Sclerosis Patients, Neuropsychological Rehabilitation (2023)
22. Primary Progressive Multiple Sclerosis in Iran: A Consensus Recommendation for Diagnosis and Management, Multiple Sclerosis and Related Disorders (2018)
23. External Validation of a Clinical Prediction Model in Multiple Sclerosis, Multiple Sclerosis Journal (2023)
24. Early Predictors of Conversion to Secondary Progressive Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2021)
25. Uveitis Among People With Multiple Sclerosis: A Systematic Review and Meta-Analysis, Survey of Ophthalmology (2025)
26. Sexual Dysfunction in Women With Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis, Sexuality and Disability (2022)
27. Comparison of Bone Mineral Density of Osteoporotic and Osteopenia Menopausal Women Treated With Oral Bisphosphonates Before Stopping the Treatment and 1 Year After Drug Holiday Period, Clinical Rheumatology (2024)
28. Multiple Sclerosis: Clinical Features, Pathophysiology, Neuroimaging and Future Therapies, Future Neurology (2009)
29. Is It Necessary to Perform Connective Tissue Disorders Laboratory Tests When a Patient Experiences the First Demyelinating Attack?, Journal of Research in Medical Sciences (2013)
30. Diagnosis and Classification of Optic Neuritis, The Lancet Neurology (2022)
31. Multiple Sclerosis: Pathophysiology, Clinical Features, Diagnosis, and Management, Neuroinflammation (2011)
32. Investigating the Prevalence of Osteoporosis Risk Factors in Postmenopausal Women Less Than 65 Years of Age Referring to Al-Zahra Hospital; [بررسی شیوع عوامل خطر پوکی استخوان در زنان یائسه کمتر از ۶۵ سال مراجعه کنندهبه بیمارستان الزهرا (س)], Journal of Isfahan Medical School (2024)
33. Diagnosis and Management of Multiple Sclerosis in Children, Iranian Journal of Child Neurology (2016)
34. The Role of Glial Fibrillary Acidic Protein As a Biomarker in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Meta-Analysis, Medicina (Lithuania) (2024)
35. Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis, JAMA Neurology (2018)
36. Gustatory Dysfunction in Multiple Sclerosis: A Systematic Review and Meta-Analysis, Chemical Senses (2025)
37. Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009–2018, CNS Drugs (2021)
38. Diagnostic Value of Clinical Parameters for the Prediction of Osteoporosis in Menopause Iranian Women, Jundishapur Journal of Chronic Disease Care (2023)
39. The Association of Ultra-Processed Food Consumption With Adult Mental Health Disorders: A Systematic Review and Dose-Response Meta-Analysis of 260,385 Participants, Nutritional Neuroscience (2023)
40. Effect of Melatonin Supplementation on Sleep Quality: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Journal of Neurology (2022)
41. Air Pollution and Bone Mineral Density, Advances in Health and Disease (2021)
42. A Systematic Review and Meta-Analysis of Prospective Cohort Studies on the Association Between Alcohol Intake and Risk of Fracture, Critical Reviews in Food Science and Nutrition (2022)
43. Effects of Stevia Consumption on Appetite in Adults: A Systematic Review and Dose–Response Meta-Analysis of Randomized Controlled Trials, Obesity Reviews (2025)
44. The Effect of Vitamin D Supplementation on Serum Levels of Fibroblast Growth Factor- 23: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Journal of Steroid Biochemistry and Molecular Biology (2022)
45. Does Supplementation With Pine Bark Extract Improve Cardiometabolic Risk Factors? a Systematic Review and Meta-Analysis, BMC Complementary Medicine and Therapies (2025)
46. Th1, Th2 and Th17 Cytokine Profile in Patients With Multiple Sclerosis Following Treatment With Rapamycin, Iranian Journal of Immunology (2016)
47. Effects of Resveratrol Supplementation on Bone Biomarkers: A Systematic Review and Meta-Analysis, Annals of the New York Academy of Sciences (2019)
48. Joint Application of Magnetic Resonance Imaging and Biochemical Biomarkers in Diagnosis of Multiple Sclerosis, Current Medicinal Chemistry (2020)
49. The Effectiveness of Natalizumab Vs Fingolimod–A Comparison of International Registry Studies, Multiple Sclerosis and Related Disorders (2021)
50. Osteoporosis Screening Tools in Iranian Postmenopausal Women, Iranian Red Crescent Medical Journal (2010)